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 INTRODUCTION
The cascade of events governing tissue specification during
vertebrate development is generally believed to be initiated by
the response of regionally distinct germ layer cells to extra-
cellular signaling cues. These signals, in turn, activate tran-
scription factor proteins which act on genes required for the
elaboration of specific cell fates. However, the molecules and
mechanisms involved in vertebrate tissue specification are still
being defined. To understand how cells achieve their ultimate
developmental fate, it is necessary to determine how signals
transduced to the nucleus mediate specific transcription factor
regulation of downstream target genes. 
Transcription factor GATA-1 is known to be an essential
regulatory protein for murine erythropoiesis, while the physi-
ological function of other members of this growing multifac-
tor family is far less well understood. Six distinct members of
the GATA family have been identified in vertebrate organisms.
Individual family members share greater identity between
species than do all of the family members expressed within one
species (Yamamoto et al., 1990; Zon et al., 1991). Further-
more, the tissue distribution of each GATA family member
appears to be highly conserved among different vertebrates.
These observations suggest that GATA factors share evolu-
tionarily conserved roles in vertebrate gene regulation (Arceci
et al., 1993; Dorfman et al., 1992; Kelley et al., 1993; Ko et
al., 1991; Trainor et al., 1990; Wilson et al., 1990; Yamamoto
et al., 1990; Yang et al., 1994; Zon et al., 1990, 1991). 
Within a single species, the amino acid sequence identity of
the GATA factors is highest within the DNA-binding domain
(Yamamoto et al., 1990) and likely, as a consequence, family
members display overlapping binding specificity in vitro (Ko
and Engel, 1993; Merika and Orkin, 1993). The GATA factors
share a common DNA sequence recognition motif composed
of two (C4) zinc fingers: only the carboxyl finger is required
for the GATA nucleotide core site-specific DNA binding
(Martin and Orkin, 1990; Omichinski et al., 1993; Yang and
Evans, 1992; Yang et al., 1994); the amino finger may specify
nuclear localization of the factor (Yang et al., 1994), and may
additionally impart alternative DNA-binding site specificity
(Whyatt et al., 1993). Outside of the DNA-binding domain, the
sequence of the GATA factors within a single species diverges
significantly. 
Confirmation that members of the GATA family play key
roles in gene regulation has been rigorously documented only
for GATA-1 (Evans and Felsenfeld, 1989; Tsai et al., 1989).
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We describe the embryonic expression pattern as well as
the cloning and initial transcriptional regulatory analysis
of the murine (m) GATA-3 gene. In situ hybridization
shows that mGATA-3 mRNA accumulation is temporally
and spatially regulated during early development:
although found most abundantly in the placenta prior
to 10 days of embryogenesis, mGATA-3 expression
becomes restricted to specific cells within the embryonic
central nervous system (in the mesencephalon, dien-
cephalon, pons and inner ear) later in gestation. GATA-3
also shows a restricted expression pattern in the
peripheral nervous system, including terminally differen-
tiating cells in the cranial and sympathetic ganglia. In
addition to this distinct pattern in the nervous
system, mGATA-3 is also expressed in the embryonic
kidney and the thymic rudiment, and further analysis
showed that it is expressed throughout T lymphocyte
differentiation. 
To begin to investigate how this complex gene expression
pattern is elicited, cloning and transcriptional regulatory
analyses of the mGATA-3 gene were initiated. At least two
regulatory elements (one positive and one negative) appear
to be required for appropriate tissue-restricted regulation
after transfection of mGATA-3-directed reporter genes into
cells that naturally express GATA-3 (T lymphocytes and
neuroblastoma cells). Furthermore, this same region of the
locus confers developmentally appropriate expression in
transgenic mice, but only in a subset of the tissues that
naturally express the gene. 
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expression, mouse
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Analysis of mice reconstituted from GATA-1-ablated ES cells
showed that these defective cells fail to contribute to erythro-
poiesis in chimeric animals (Pevny et al., 1991); differentiation
of the same GATA-1-deficient ES cells also fail to give rise to
mature erythrocytes in vitro (Simon et al., 1992). GATA-1 is
expressed at all developmental stages of erythropoiesis, as well
as in mast cells, megakaryocytes and Sertoli cells of the testis
(Ito et al., 1993; Martin et al., 1990; Romeo et al., 1990;
Whitelaw et al., 1990; Yamamoto et al., 1990; Yomogida et
al., 1994). GATA-2 is more broadly expressed than GATA-1
(Dorfman et al., 1992; Yamamoto et al., 1990), while GATA-
4, GATA-5 and GATA-6, the most recently identified family
members, appear to constitute a distinct subfamily that is
expressed in the developing heart and gut (Arceci et al., 1993;
Kelley et al., 1993; Lavernere et al., 1994; Tamura et al., 1993).
Thus with the exception of GATA-2, the vertebrate GATA
factor family members described to date appear to be distinct
in their individual expression patterns. 
GATA-3 was first identified as an abundantly expressed
mRNA in chicken, mouse and human T lymphocytes and in
the embryonic chicken and murine brain (Ko et al., 1991;
Kornhauser et al., 1994; Leonard et al., 1993; Yamamoto et al.,
1990). Although no target genes have yet been identified in the
nervous system, GATA-3 activity has been shown to be
required for stimulation of the T cell receptor (TCR) genes
(Joulin et al., 1991; Ko et al., 1991; Redondo et al., 1990,
1991), the 
 
CD8α gene (Hambor et al., 1993; Landry et al.,
1993) and the HIV-1 LTR (Yang and Engel, 1993) in T cells. 
The initial step in defining the role(s) that a regulatory
protein may play in development is to document where and
when it is both first and then persistently expressed during
normal embryogenesis; once the normal expression pattern is
established, one may then focus subsequent studies on specific
candidate tissues or target genes. Using in situ hybridization,
we show that mGATA-3 is expressed at previously identified
as well as new anatomical sites during murine embryonic
development: in addition to expression in the thymic rudiment
and at the earliest stages of T lymphocyte differentiation,
mGATA-3 was found to be expressed in highly restricted
groups of cells within the placenta, in the peripheral and central
nervous systems (PNS and CNS) and in the embryonic liver,
kidney and adrenal gland. 
To initiate transcriptional regulatory analyses, we isolated
and structurally characterized the mGATA-3 gene. We then
employed both transient transfection and transgenic mice to
determine the position of mGATA-3 regulatory sequences.
These data suggested that cis-regulatory elements required for
tissue-restricted expression of this factor lie within 3 kbp sur-
rounding the transcriptional initiation site. The transgenic
embryos displayed an appropriately regulated mGATA-3
expression pattern in most tissues. However, this presumed
mGATA-3 transcriptional regulatory domain appeared to be
missing element(s) required in vivo for specification of CNS
transcriptional control. 
MATERIALS AND METHODS
In situ hybridization
In situ hybridization was performed as described previously
(Wilkinson, 1987) using equal cts/minute of T7 RNA polymerase-
derived [35S]UTP-labeled, single-stranded riboprobes. The mGATA-
3 antisense probe was a linearized exoIII-deletion of the full-length
cDNA, mc5b1 (Ko et al., 1991). For autoradiography, slides were
coated with Kodak NTB2 film emulsion and kept under desiccant at
4°C 1-2 weeks. After developing, the sections were counterstained
with cresyl violet. 
Oligonucleotides: RT/PCR and primer extension
Quantitative RT-PCR analysis was performed with mGATA-3
primers and mS16 primers, as previously described (Leonard et al.,
1993). Oligonucleotides used for primer extension were mG3PE1
(5′...GAGTAGCAAGGAGCGTAGAGGAGGA...3′, corresponding
to nt +187 to +163) and mG3PE2 (5′...CTTTGCGGGATAGTT-
TAGCAA...3′, corresponding to nt +814 to +794). The sense strand
corresponding to both oligonucleotide sequences is shaded in Fig. 5C.
Cloning
Approximately 3×106 pfu of a λFIXII BALB/c genomic library (a gift
from D. I. H. Linzer) was screened at high stringency with a random-
primed full-length mGATA-3 cDNA. Purified phage were subdivided
based on whether they hybridized to a probe containing either 5′ or
3′ cDNA sequences. The longest clones, which corresponded to the
5′ or 3′ end, were subcloned into pGEM7Zf(+) or pBluescript vectors
(Promega, Inc. and Stratagene, Inc., respectively). The clones were
characterized by Southern blotting and exon-intron boundaries were
identified. The exon-intron boundaries, as well as the region upstream
of the cap site, were sequenced by dideoxy-chain termination of the
double-stranded plasmids (Choi and Engel, 1986; Sanger et al., 1977).
The EMBL gene bank accession number for the sequence shown in
Fig. 5C is Z33620.
Flow cytometry
CD4- and CD8-positive thymocyte subpopulations were isolated
using two-color analysis as previously described (Robey et al., 1991).
Cells were then lysed for RNA RT/PCR analysis (above) as described
(Leonard et al., 1993).
Plasmid constructions 
pR1.3HNC
Plasmid subclone R1.3 of genomic recombinant λ7e (Fig. 7A) was
used as the base plasmid to substitute the neomycin resistance (neoR)
open reading frame for mGATA-3 translation initiation coding
sequences. The 5′ primer (mG3USPC1Hind; 5′...GCAGG-
AAGCTTGCGAAGACCT...3′) corresponds to nt +518 to +538
(spanning the HindIII site, underlined) in intron 1 (Fig. 7C), while the
3′ primer (mG3DSPC1Nco; 5′...CACCTCCATGGCCTCG-
GCTGT...3′) matched the flanking sequences of the translation
initiation codon (underlined; Ko et al., 1991) but converted sequences
surrounding the mGATA-3 translation initiation codon to a NcoI site.
The neoR gene was amplified from pMC1NeoA+ (Stratagene) using
primers NeoA+5′PC1 (5′...AGCCACCATGGGATCGGCCATT-
GA...3′; which converts the neo gene translation initiation codon to a
NcoI site; underlined) and NeoA+3′PC1 (5′...GGCTGCAGATC-
GATGGATCCGAAC...3′) which introduces a ClaI site (underlined)
at the 3′ end of the neoR coding sequences. The PCR amplified and
restriction enzyme digested mGATA-3 HindIII-NcoI fragment was
then ligated to the amplified and restriction enzyme digested neoR
NcoI (partial)-ClaI fragment, and the resulting HindIII-neoR-ClaI
fragment was used to replace the internal HindIII-ClaI fragment of
R1.3 (Fig. 7C; the ClaI site is in intron 2, not shown).
308pCAT
pR1.3HNC (above) was digested to completion with NcoI and
partially digested with NsiI (nt +47 to +52; Fig. 5C). After repairing
the ragged ends, the CAT structural gene isolated from pJFCAT1
(Fridovich-Keil et al., 1991) was then ligated to this vector. 
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308pI1CAT
pRI.3HNC was digested with NcoI (nt +1002 to +1004; Fig. 5C) and
partially filled (using Klenow polymerase with dCTP and dATP), and
then ligated to the CAT structural gene from pJFCAT1 to generate
308pI1CATI2. The plasmid was then digested with SacI, and the
largest fragment was isolated and religated to generate 308pI1CAT.
5′ deletions of the proximal promoter (from −308 in a 5′ to 3′
direction, referred to in the text) were generated by ExoIII-S1 nuclease
digestion of this plasmid.
∆Sac2
308pI1CAT was digested with SacII (sites underlined in Fig. 5C), and
the large fragment (containing the internally deleted mGATA-3
sequences plus vector) was isolated and ligated. 
308pI1mCAT
The inverted GATA site in the first intron of 308pI1CAT (nt +233 to
+240; boxed in Fig. 5C) was mutated by insertion of a SalI linker into
the natural EcoRV site (5′-TTGATGGTCGACCATC-3′; the added
linker sequences are underlined). 
(I1+) and (I1−)308pCAT
I1 was amplified by PCR, using primers incorporating SphI sites on
the ends to facilitate subcloning into pGEM7. Oligonucleotide
primers used were: mG3INSDS (5′...GGATGCATGCCTG-
CAAGGGAGAGAA...3′) and mG3INSUS (5′...GGATGCATGCG-
GTTGGTATTGTGAC...3′). The PCR products were digested with
SphI, and ligated to 308pCAT which had been digested with SphI (a
unique SphI site is in the residual polylinker at the 5′ end of
308pCAT). The subclones were sequenced to confirm the two orien-
tations of I1. 
1754pI1CAT
308pI1CAT (above) was digested with XhoI (in the residual multiple
cloning site of pGEM7), ClaI linkers were added, and the resulting
plasmid was digested with ClaI and HindIII (located in I1, above).
The largest fragment was isolated and then ligated to a 2.3 kb genomic
ClaI (−1754)-HindIII (+524) fragment isolated from genomic clone
λ7e to extend the contiguous mGATA-3 genomic sequence of
308pI1CAT to nt −1754 to generate 1754pI1CAT (Fig. 5C). 5′
deletions of this subclone were generated by ExoIII-S1 nuclease
digestion of 1754pI1CAT (Henikoff, 1984), and sequenced to
determine the extent of digestion. The clones 1203pI1CAT,
1475pI1CAT and 1754pI1CAT used in the transient transfection
analysis (endpoints shown as rightward arrows in the 5′ flanking
sequences in Fig. 5C; see also Fig. 7) were generated from this set of
5′ deletions.
2052pI1LacZ
The lacZ gene was isolated by digestion of pNASSβ (Clontech Inc.)
with NotI and then filled using Klenow polymerase plus dNTPs. The
lacZ insert was then ligated to pR1.3HNC which had been digested
with NcoI and then treated with S1 nuclease to create intermediate
308pI1lacZ. This plasmid was then digested with XhoI (in the residual
pGEM4 polylinker) plus HindIII and then ligated to the 2.6 kbp XhoI-
HindIII fragment of genomic clone λ7e (from nt −2052 to +523; Fig.
5C) to generate 2052pI1lacZ.
Cell culture and transient transfection assays
Cell lines were purchased from American Type Culture Collection
(BW5147.3, CH27), or were gifts from D. I. H. Linzer (BALB/c 3T3),
R.I. Morimoto (NIH 3T3), V. Patel (MEL), or B. Mirkin (C1300).
3T3 cells were grown in DME containing 10% heat-inactivated fetal
bovine serum plus penicillin/streptomycin. C1300 cells were grown
in DME containing 10% heat-inactivated fetal calf serum, 1 mM
sodium pyruvate (Sigma), and penicillin/streptomycin. BW5147.3
cells were grown in DME containing 10% heat-inactivated horse
serum and penicillin/streptomycin.
3T3 cells were transfected in triplicate using the calcium phosphate
procedure (Ausubel et al., 1989; Graham and van der Eb, 1973).
Approximately 1.7 pmole of each test plasmid and 1 µg pRSV.LUC
were transfected. pBluescript was added to bring total amount of DNA
to 10 µg. Briefly, cells were passaged the day before transfection at
a density of 5×105 cells/100 mm plate. DNA was suspended 250 mM
CaCl2. 2× Hepes-buffered saline (50 mM Hepes acid pH 7, 280 mM
NaCl, and 1.5 mM Na2HPO4) was added and vortexed. After 30
minutes, the precipitate was added to plates of cells. Cells were
washed in PBS and fresh media was added approximately 16-20 hours
after transfection. 
BW5147.3 and C1300 were transfected in duplicate using DEAE-
dextran (Choi and Engel, 1986). Briefly, 107 cells were incubated at
room temperature for 30 minutes with the DNA (the same concen-
trations used for 3T3 transfections) and either 500 µg/ml (BW5147.3)
or 100 µg/ml (C1300) DEAE-Dextran (Mr 5×105; Pharmacia). Cells
were then washed and plated in 20 ml of complete media. 
Cell lysates were prepared 48 hours after transfection by the freeze-
thaw procedure (Rosenthal, 1987). Luciferase assays were used to
determine transfection efficiency and CAT assays were performed
using equal amounts of extract (Ausubel et al., 1989). The percent-
age of acetylation for each extract was determined by quantification
of the 14C-acetylated chloramphenicol on thin-layer chromatography
plates using a Molecular Dynamics PhosphorImager. The per cent
acetylation was then normalized to luciferase activity to correct for
transfection efficiency. 
Transgenic mice: transient embryo analysis and embryo
staining
A DNA fragment (2052LacZ) containing the mGATA-3 gene directing
β-galactosidase synthesis (above) was removed from vector
sequences by restriction enzyme digestion followed by preparative
agarose gel electrophoresis. The DNA was finally purified using Gene
Clean (Bio 101) followed by an Elutip column (Schleicher and
Schuell). The DNA was resuspended into microinjection buffer con-
sisting of TE (10 mM Tris-HCl, 0.2 mM EDTA, final pH = 7.5) and
microinjected into fertilized oocytes from (C57Bl10 × CBA) F1 mice.
Eggs surviving injection were then transferred into oviducts of
recipient pseudopregnant females (Dillon and Grosveld, 1993; Hogan
et al., 1986).
Embryos were then isolated at days 10, 11 and 12 of gestation and
fixed in 1% formaldehyde, 0.2% gluteraldehyde, 2 mM MgCl2, 5 mM
EGTA and 0.02% NP-40 in PBS. They were then washed with PBS
and stained in the dark, overnight at ambient temperature in 1 mg/ml
X-gal (Whiting et al., 1991). Transgenesis was determined by
Southern blotting of placentae recovered from individual embryos.
RESULTS
mGATA-3 expression during embryonic
development
RNA in situ hybridization was performed to define the sites
and times of mGATA-3 expression during embryonic devel-
opment. Embryos from 8.0 days p.c. (e8.0) through 14.5 days
(e14.5) of gestation were examined, and specific organs and
tissues were identified by comparison to depicted sections
(Kaufman, 1992). Tissue sections were hybridized to sense or
antisense transcripts prepared from mGATA-3 cDNA clone
mc5b1 (Ko et al., 1991). The probes did not contain sequences
corresponding to the zinc fingers of mGATA-3 to preclude the
possibility of cross hybridization to other members of the
GATA factor family (Yamamoto et al., 1990). 
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Fig. 1. mGATA-3 expression in mouse embryogenesis at e8-e10.5. Whole decidua were sectioned and in situ hybridization was performed
(Materials and Methods). (A,B) Bright- and dark-field illuminations of the same cross-section through an e8.0 embryo. mGATA-3 mRNA is
not detectable in embryonic tissues in this section, or in equivalent aged embryos. The unclosed neural tube is indicated (nt). Significant signal
is detected in extraembryonic cells. (C,D) Strong hybridization is detected in the ectoplacental cone (ec) and trophoblast cells (tr). No
embryonic tissue is present in this section. (E) A cross-section in different planes of two separate e10 embryos is shown. The upper left embryo
shows expression in the spinal cord (sc) and somites (so), the lower right embryo shows expression in the otic vesicle (ov) and hindbrain (h).
(F) Expression is detected in another e10 embryo in the front of the telencephalon (t), the otic vesicle, in trigeminal ganglia (TG) and ganglia of
the facio-acoustic complex (FA). Expression in the eye (op) is detected at low levels in this section. (G) An oblique cross-section (taken at
higher magnification than in E) of an e10 embryo showing expression in the otic vesicle and hindbrain. (H) A cross-section through the caudal
end of an embryo showing expression in the spinal cord, somites, and mesonephric ridge (mn). 
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At e8, we did not detect expression of mGATA-3 mRNA in
the embryo (Fig. 1A,B). Significant expression is, however,
detected in the ectoplacental cone and trophoblast cells sur-
rounding the embryonic cavity (Fig. 1C,D), in agreement with
the studies of Ng et al. (unpublished data) who found abundant
mGATA-3 expression in placental trophoblast cells.
At e10 mGATA-3 is expressed at varying levels throughout
the CNS (Fig. 1E-H). Localized expression is detected in the
Fig. 2. mGATA-3 expression in mouse embryogenesis at e11.5-e12.5. (A,B) Bright- and dark-field illumination of a sagittal view of an e11.5
embryo. Expression along the pons and pontine flexture (p), and the mesencephalon (ms). The liver (L) also expresses GATA-3, as do the
dorsal root ganglia (drg). Telencephalon (t), nose (n) and heart (h) are shown in bright field for orientation. (C,D) Bright- and dark-field
illumination of the same section. Expression is found in the sympathetic ganglia (sg), more dorsally in the spinal cord (sc), dorsal root ganglia
(drg), vitelline vein (V), liver (L) and the mesonephric ridge (mn). (E,F) Cross-sections through an e12.5 embryo in a progressively rostral-to-
caudal direction. (E) Expression is detected in the outer half of the mesencephalon (ms). (F) A cross-section through the head, showing
expression restricted to two sets of bilaterally symmetric groups of cells in the ventral half of the diencephalon (di), as well as persistent high
expression in the pons (p). (G) mGATA-3 is expressed at high levels in sympathetic ganglia (sg) and spinal cord (sc) expression is now
restricted to the ventral half. 
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somites (Fig. 1E,H). In an e10.5 embryo (Fig. 1F), localized
mGATA-3 expression is detected in the anterior end of the
telencephalon, in the otic vesicle and in ganglia of the periph-
eral nervous system (PNS), including trigeminal ganglia and
ganglia of the facio-acoustic complex. GATA-3 is also
expressed in the developing eye (Fig. 1F,G) and in clusters of
cells along the mesonephric ridge (Fig. 1H).
By e11, expression is still diffuse throughout much of the
CNS, with more localized expression within the walls of the
midbrain (the mesencephalon). A sagittal view (Fig. 2A,B)
shows that expression is extensive in the pons and pontine
flexure, with a discrete rostral boundary. GATA-3 continues to
be expressed in the otic vesicle and many ganglia of the PNS
(data not shown). A transverse section reveals specific
expression in the sympathetic ganglia, spinal cord and dorsal
root ganglia, and also in localized regions of the developing
heart, liver, mesonephric ridge and the vitelline vein (Fig.
2C,D). 
At e12.5, mGATA-3 mRNA has become more restricted in
expression within the mesencephalon and accumulates in the
outer half (Fig. 2E). At this stage, GATA-3 continues to be
expressed in the pons/myelencephalon and becomes restricted
to two bilaterally symmetric groups of cells in both halves of
the diencephalon (Fig. 2F). Sympathetic ganglia still express
GATA-3 mRNA, while expression in the dorsal root ganglia
is no longer detected and expression in the spinal cord has
become restricted to the ventral half (Fig. 2G). 
At e14.5, expression in the diencephalon appears unchanged
from e12.5 (Fig. 3A shows a representative sagittal section).
mGATA-3 mRNA continues to be present in the pons but in
an even more spatially restricted pattern than at e12.5 (Fig. 3A
and data not shown). Expression in the mesencephalon persists,
but remains removed from the immediate layer of cells
overlying the ventricle (Fig. 3A), while expression in the spinal
cord has declined significantly (data not shown). GATA-3 is
not detected in the spinal cord at the approximate level of the
most rostral cervical vertebra, but is detected in more caudal
sections in the ventral half of the spinal cord at significantly
lower levels than on previous days of development. mGATA-
3 mRNA is still expressed in the inner ear and in ganglia of
the PNS (including both cranial and sympathetic ganglia; data
not shown). Expression is detected in the thymic rudiment
(data not shown), coincident with the time when CD4−CD8−
prethymocytes migrate to this region (Penit and Vasseur,
1989). GATA-3 transcript is also detected in the vomeronasal
organ (Fig. 3B), in glomeruli of the kidney and in the adrenal
medulla (Fig. 3C,D).
In summary, GATA-3 mRNA expression in the develop-
ing mouse embryo was found to be widespread and tempo-
rally dynamic. Early in development (prior to e10), GATA-
3 was expressed at very low levels, if at all, in the developing
embryo. During the next several days of gestation, the
relative abundance of GATA-3 mRNA increased and subse-
quently declined at several sites, and GATA-3-expressing
cells became highly restricted to, and persistent in, morpho-
logically and anatomically distinct groups within the CNS
and PNS, the kidney and adrenal medulla and in the primitive
thymus. 
mGATA-3 expression during murine T cell
differentiation 
GATA-3 is expressed in all T lymphocyte cell lines that have
been examined (Ko et al., 1991; Leonard et al., 1993;
Yamamoto et al., 1990) and in the rudimentary thymus at the
earliest embryonic stages defining the organ (Penit and
Vasseur, 1989; data not shown), suggesting that it serves an
early and therefore physiologically important function in T cell
ontogeny. To test this hypothesis, experiments were under-
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Fig. 3. mGATA-3
expression in mouse
embryogenesis at
e14.5. (A) A sagittal
section showing
expression in the
mesencephalon (ms),
diencephalon
(indicated by arrow;
di) and pons (p).
(B) mGATA-3 is
expressed in the
vomero-nasal organ
(VNO), but not in the
rest of the nasal cup
(nc). (C,D) Bright-
and dark-field
illuminations of the
same section.
mGATA-3 is
expressed in the
kidney (k) and adrenal
medulla (a). 
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taken to ascertain when mGATA-3 expression commenced
during normal T lymphocyte differentiation. 
Thymocytes were sorted by flow cytometry according to
expression of the CD4 and CD8 antigens (Materials and
Methods). RNA was recovered from the sorted cells, and
RT/PCR was performed using oligonucleotides specific for
mGATA-3 (Leonard et al., 1993). mGATA-3 was expressed
in all four T lymphocyte fractions (CD4−CD8−, CD4+CD8+,
CD4+CD8−, and CD8+CD4−; Fig. 4A, lanes 5-9, respectively).
CD4+ cells expressed mGATA-3 at somewhat higher than
CD8+ cells, but all lymphocyte subpopulations examined
expressed mGATA-3 mRNA. Since CD4−CD8− T cells define
a very early stage of T lymphopoiesis, these data suggest that
mGATA-3 is involved in very early aspects of T lymphocyte
differentiation. 
Fig. 4 also shows that mGATA-3 is expressed in a number
of murine cell lines: BW 5147.3, EL4 (mouse T cell lines) and
C1300 (a mouse neuroblastoma line; Pons et al., 1982) cells
express abundant mGATA-3 mRNA (Fig. 4A, lanes 1 and 2),
while BALB/c 3T3 fibroblasts do not (Fig. 4B, lanes 1, 2 and
4; Landry et al., 1993). mGATA-3 mRNA is prevalent in
embryonic stem cells, but its abundance decreased dramati-
cally after in vitro differentiation (Fig. 4B, lanes 5-7; Keller et
al., 1993; Lindenbaum and Grosveld, 1990). These studies
were extended by immuno-precipitation experiments
employing anti-mGATA-3-specific monoclonal antibodies;
they confirmed that GATA-3 mRNA expression parallels the
accumulation of abundant GATA-3 protein in T cell lines and
in C1300 neuroblastoma cells (Ng et al., unpublished data;
Yang et al., 1994). The (murine) monoclonal antibodies,
however, failed to recognize mGATA-3 in either embryonic
whole mounts or tissue sections (M. E. R., data not shown).
Structure of the 
 
mGATA-3 gene
In order to initiate regulatory analysis of the mGATA-3 gene,
the locus was cloned and characterized. A murine BALB/c
genomic DNA library (a gift from D. I. H. Linzer) was
screened (Maniatis et al., 1982) using an mGATA-3 cDNA
clone (plasmid mc5b8; Ko et al., 1991) as probe. Positive
clones were plaque-purified using probes corresponding to
either the 5′ or 3′ ends of the mGATA-3 cDNA. Four inde-
pendent mGATA-3 genomic recombinants (λ7e, λ5a, λ2b,
λ10b) were further characterized by restriction enzyme
mapping and then subcloned into plasmid vectors. The final
map of the mGATA-3 gene was determined using these indi-
vidual subclones as probes in Southern blotting of the parental
λ recombinants (Fig. 5A). 
The overlapping genomic λ clones were found to describe
the entire coding region of the mGATA-3 locus [approximately
23 kilobase pairs (kbp)]; they also contained 13 kbp of 5′ and
8 kbp of 3′ flanking sequence (Fig. 5A). The gene is composed
of six exons: the first exon (E1) consists entirely of 5′ untrans-
lated sequence while the second exon (E2) contains the
initiation codon for mGATA-3 translation (see below). The
amino and carboxy zinc fingers are encoded in exons E4 and
E5, respectively, while the 3′ untranslated region and
polyadenylation signal are located within E6 (Fig. 5B). The
intron-exon boundaries were shown to conform clearly to the
general splicing consensus (Fig. 5B; Mount, 1982). Thus the
overall organization of the mGATA-3 gene is quite similar to
that of the mGATA-1 and cGATA-1 factor genes (Hannon et
al., 1991; Tsai et al., 1991). 
Primer extension assays were performed to identify the
mGATA-3 transcription initiation site. RNA was isolated from
BW5147.3 (mouse T lymphoma) and MEL (mouse ery-
throleukemia) cells; mGATA-3 is abundantly expressed in a
variety of murine T cell lines (Fig. 4), but expressed at only
very low levels in MEL cells (Leonard et al., 1993). Primer
extension (Leonard and Patient, 1991) of BW5147.3 mRNA
using primers corresponding to sequences within exon 1
(mG3PE1) or exon 2 (mG3PE2; Materials and Methods),
yielded products of 187 and 395 nucleotides (nt), respectively
(Fig. 6A, lanes 11 and 12 and Fig. 6B, lanes 1 and 2). The
endpoints determined with the two different primers were
identical. 
S1 nuclease protection assays were also used to confirm the
site of mGATA-3 transcriptional initiation. Kinase-labeled
oligonucleotide mG3PE1 was annealed to genomic subclone
R1.3 (Fig. 6A) containing the (presumptive) first exon and 308
bp of 5′ flanking sequence of the mGATA-3 locus, and
extended using Klenow polymerase. This probe was then
Fig. 4. Expression of mGATA-3 during T-cell development and in
murine cell lines. Total cellular RNA was isolated from T
lymphocyte lines BW 5147.3 (A, lanes 1, 2) or EL4 (B, lane 1),
neuroblastoma line C1300 (B, lane 2), B lymphocyte line CH27 (A
and B, lanes 3), BALB/c 3T3 cells (B, lane 4) or circulating
lymphocytes (A, lane 4); the circulating lymphocytes were further
fractionated by cell sorting into populations expressing CD8 and
CD4 antigens (A, lane 7), neither CD4 nor CD8 (A, lanes 5, 6), only
CD4 (A, lane 8) or only CD8 (A, lane 9). ES cells were either
propagated normally (panel B, lane 5) or subject to in vitro
differentiation for 9 days (B, lane 6) or 12 days (B, lane
7)(Lindenbaum and Grosveld, 1990). RNAs were then reverse
transcribed and co-amplified by PCR using internal control (murine
S16 mRNA) primers as described (Materials and Methods; Leonard
et al., 1993).
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              EXON 1 (noncoding 5' end; 189 nt)...TCAGgttggt...Intron 1 (418 nt)...
ttgcagGTGA....EXON 2 (ATG; 630 nt)................CACGgtgagt...Intron 2 (2.5 kb)...
tcacagGGAG....EXON 3 (536 nt).....................ACAGgtgagt...Intron 3 (6.5 kb)...
ttccagAAGG....EXON 4 (amino finger; 145 nt).......GCTGgtaagt...Intron 4 (5.6 kb)...
atccagTCGG....EXON 5 (carboxy finger; 125 nt).....TAATgtaagc...Intron 5 (5.5 kb)...
ttttagATT.....EXON 6 (3' end; 828 nt)
C
  -2052                                                     ct cgagactttt ctcgaagctg tgaactaggg actggctgac tgatgcctta
  -2000 tacaactcat gagtgataca gcaatagtat ttttcccttt taaactctca ttctagatct taatcccggg ccttttagca aaaatgtgtg tgcggtcttc
  -1900 tctgcttgtt tatggaatgg tttccggtga atgttagaca gcaactaaat aattaaaagg ttttgagagc gccgtgagct ggaagagatg ctggcagctt
  -1800 gattggccca ggagagatgg gttggtcaaa gagtgaaagt aaaaaaatcg atattctaag actgggccgc cctcataaac gtgggaccaa ggggtgcagg
  -1700 gtgaactcag aagggaggga agactcgttt ttaaaaaaaa ggtatcttcg taatttgtat ttagaaattc agccttgatt tcagtcaaag atcagatgta
  -1600 aaaggggggg gggtgtcagg agaagctcca aacccaagcc cgcacaggca tttctaaata aattttgtct tcttcaaggg ttgtattgta aaaagaacgc
  -1500 accttccctc tccccgcact ccactggctt caaggtagat attgatggct tttctccaca gtagaataga agaagttact tggaactttt aagaaagggc
  -1400 ttgtcgggaa tccaagtttt gaataagtgg gaaatattat ggggtaaaga aatgaagagg ggatgacgcc ttcagttcca gtaaccctct aaagccaagc
  -1300 tctctgccct ggagggtgga atgggaacac ctcttacact gccctggggt gcacccgaag tctctttcgg accttgctca tccgggcagt gttttctgga
  -1200 cccaggctgc agaaacctca acgccactag gggatgcagt gactcaaagg acggaacagg gccgcagagg ttggagcccg tggggcgggg cgactgcggc
  -1100 ccggtcgtgg tatctcccga tgattggtcc ttacaaatgg ccccgccctc gtccgcccag cctctctact gggcgtcttc cagcctctct cctgtgtcag
  -1000 cttgcgccct ccctccagac cctgtccaga gacccaaaat gtcagggaag ttgcggctgg gtcaccccgg aggtcagggt tggatattat agaggggacc
   -900 gttttcctcg ggtgaaagca gaataaagta gcaccccgag ctaggcgaag agaaaagtta ggctatcgca gcaaagatca agttagttgt acacggtact
   -800 tcggggacca gtgagcctag gtctcgctaa gccagctttt tatgcatcgc gttgtcacta aggtcaaaag cacacattga tgatatcatt agatccgaaa
   -700 aagacagctc gcaacagtga cgctgttcgt tctggagagg tttgggaaag caagcagaga ccataacaat aacgcgggcg tccgaatcaa agcccaggtc
   -600 ctccgcgcga ttcagcagcc tcccggaaag ctggttcgga ggcaaatctt cagttacttc gccatgaaac ttttctaatc tgttttacat gcacatagcc
   -500 cctaagctga tataaactga aaaacgttct ggcttgaatc ctaatttaaa agtttgctca tttttaaaaa agtatcgaaa agtctgctta tggaaattag
   -400 ctttatgaat ggggcagccg ggtttcactc gtacggaata atctactgag cccgaatgaa tcggctttgc tacatttaaa gggccagaga gcgaattccc
   -300 tcctgcctgt cccctctgcc ccaagcccgg gcgggcctcg cccaccctgc ccgcggcccc tctgccctag gcggcccttg gcggcgcccc tttccggtca
   -200 gtagaggggc gggaggaggg gcggcggtgt gccggggtgg gtggggggga tgggatgggg gtggaggtga agtcctggag cgggtttggg ttgcagtttc
   -100 cttgtgctga ggatcgtgta ccctcctgcc accgcaggct cctccccctc ggcgcggatg acactagaac ctccttaagt tgcgtcgcgc cacagctgtc
     +1 TGCGAACACT GAGCTGCCTG GCGCCGTCTT GATAGTTTCA GAAAGAATGC ATTCCCTGTA AAAAAAAAAT ACTGAGAGAG GGAGAGGAGA AAGAGAGAGA
   +101 GACTGAGAGA GCGAGACATA GAGAGCTACG CAATCTGACC GGGCAGGTCA CACGCCTCCT CCTCCTCCTC TACGCTCCTT GCTACTCAGg ttggtattgt
   +201 gacttgtgac tttttttttt tttttaagtt tgatatcact ccctcctctt ggagggactg tttgtgtgtg tgtgtttggg ggtttgtttg tttggttttt
   +301 tgtaaactaa aagctcagct ttctcctttt ggaggatttg tagtggttgg aaagatcctg gggycggtgt cctccaggga ggacttgtcc caagttttaa
   +401 ttgcttagtc agtcctgggc tcctgcgagc ctggctgtcg gaggtgtgct gcggagcttg gcttctttnc nccgggactt cgngtgcgtg tgcacgtccc
   +501 gggtgagtcg gccctgcagg aagcttgcga agacctagtg ccctcccaga attcaggtgt taaaagttct tacacctcat tcaggtctct ctttctctcc
   +601 cttgcagGTG ATCGGAAGAG CAACCGTCTC TGAGCGCCAA GGAATCAGTG TGCAGTGTGG TCACACTCGG ATTCCTCTCT CCCTCCTTTT TTTTTTTTTT
   +701 TTTTTGACCC CTTTATTCCT CCGTGTCTGC TTTTTTTTTG GGGGGGGGGA TCGCCCTCAT TCTTTTCTTT TTCTTCTTTC CCTTCCTTTC TTTTGCTAAA
   +801 CTATCCCGCA AAGATTTTTC TTTCCTCCCT AAACCCTCCT TTTTGCTCTC CTTTTCTATA CCCTTAACTG CAAACAAACC ATTAAACGAC CCCTCTCCTG
   +901 GGCCTCCGAC GGCAGGAGTC CGCGGACCTC CCAGGCCGAC AGCCCTCCCT CTACCCGCGA GGTTCCGGGC CGGGCGAGAG GGCGCGAGCA CAGCCGAGGA
  +1001 CATG
Fig. 5. Structure and partial sequence of the murine GATA-3 gene. (A) The overall organization of the mGATA-3 gene is shown on the top line:
E1 through E6 represent the approximate sizes and positions within the locus of each of the mGATA-3 exons, where filled boxes indicate
translated, and open boxes untranslated, sequence. Dashed lines indicate the positions of each of the introns. The second line depicts an
abbreviated restriction enzyme map for the mGATA-3 locus, drawn to the same scale, using restriction enzymes SacI (S), BamHI (B), EcoRI
(R), HindIII (H) or NotI (N). The four parallel lines beneath the restriction map indicate the approximate sizes and degree of overlap of the four
genomic λ clones describing the locus, and the subclone of λ7e (R1.3) used for construction of transient transfection and transgenic reporter
genes (Materials and Methods). (B). Intron-exon organization of the mGATA-3 locus. (C). DNA sequence of mGATA-3 from the most CAP-site
proximal genomic XhoI site (−2052) through the translation initiation codon in the second exon (+1002, ATG, heavily underlined). Capital
letters indicate nucleotides present in mGATA-3 mRNA (Ko et al., 1991), while lower case letters represent 5′ flanking or first intron
sequences. Nucleotide +1 was assigned on the basis of S1 and primer extension assays (Fig. 6). The arrows depict each of the 5′ end of deletion
endpoints examined in transient transfection assays (Fig. 7). The heavy vertical bar (at nt +50) indicates the position where the minimum
promoter (beginning at nt −308) was linked to the CAT gene in transient transfection assay (Fig. 7A). The double GATA-binding site in the first
intron referred to in the text is boxed, while the transcription initiation site deletion construct (∆SacII; Fig. 7B) was generated by cleaving with
SacII at the two sites indicated by underlining (centered at −248 and +924). The two sequences corresponding to primer extension
oligonucleotides mG3PE1 and mG3PE2 (Materials and Methods) are shaded.
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hybridized to total RNA isolated from BW5147.3 cells. After
digestion with S1 nuclease, the protected fragment was found
to migrate with a mobility of 189 nt (Fig. 6A, lanes 1-3),
showing that the primer extension and S1 nuclease protection
products correspond to the same nucleotide. No specific
product was identified using MEL cell mRNA in primer
extension (Fig. 6A, lanes 4-7 and Fig. 6B, lanes 3, 4) or S1
nuclease protection experiments (Fig. 6A, lanes 13, 14). 
Transcriptional regulation of mGATA-3: transfection
into murine cell lines
Transient transfection assays were initially employed to
identify cis-regulatory elements that might be responsible for
the tissue-restricted expression pattern of mGATA-3. Con-
structs containing segments of the mGATA-3 locus driving
expression of the chloramphenicol acetyltransferase (CAT)
reporter gene were transfected into GATA-3-expressing and -
non-expressing cell lines. CAT enzyme activity was deter-
mined from extracts normalized for transfection efficiency
based on cotransfected pRSV.luciferase activity. A neuroblas-
toma line, C1300, and a T lymphoma line, BW5147.3, were
used as representative examples of cells that express mGATA-
3 in neural crest-derived neuronal (neuroblastoma; NB) or T
lymphocyte (T) cell lineages, respectively (we were unable to
identify a CNS cell line that expresses GATA-3 for these
studies). BALB/c 3T3 fibroblasts cells do not express
mGATA-3 (Fig. 4B, lane 4) or other GATA-binding activities
(Landry et al., 1993), and were used as a negative control. 
A segment of the mGATA-3 gene encompassing the pre-
sumptive minimal promoter, from nt −308 to +50 (Fig. 5C),
was examined first (Fig. 7A). After transfection into all three
cell lines, the transcriptional activity was significantly higher
(from 6- to 50-fold) than that of a plasmid in which sequences
surrounding the mGATA-3 CAP site were deleted (∆Sac2;
compare Fig. 7, rows A and B). Since the transfection effi-
ciency between cell lines varied significantly, changes in tran-
scription levels were normalized to the relative activity of
308pCAT (set equal to 1; Fig. 7A). 
We next examined a plasmid containing contiguous DNA
sequences from −308 through the mGATA-3 translation
initiation codon in exon 2, at nt +1002 to 1004 (Fig. 5C). This
plasmid was 7-fold more active in T cells and 4-fold more
active in NB cells, but no more active in 3T3 cells, than
308pCAT. Thus a positive transcriptional stimulatory element
appears to reside within the region that also contains the
mGATA-3 first intron (I1). Deletion of 308pI1CAT from the 5′
end to nucleotide −50 had no effect on CAT activity (data not
shown), suggesting that this positive transcriptional cis-
effector sequence lies between nt +50 and the translation
initiation codon. 
We next assayed sequences extending 5′ to −308 of the
mGATA-3 promoter. 1203pI1CAT showed unaltered tran-
scriptional activity in GATA-3-expressing cells, but had sig-
nificantly lower activity in fibroblasts (compare Fig. 7C,D).
The net effect of including additional promoter sequence was
to lower non-specific (3T3 cell) transcription, leading to more
than 10-fold higher activity of 1203pI1CAT in GATA-3-
expressing cells than in fibroblasts. Addition of even further 5′
sequence, including all of the sequence shown in Fig. 5C, had
no effect greater than 2-fold (Fig. 7E,F and data not shown). 
Since the addition of nt +50 through +1002 to a minimal
promoter stimulated transcription in cells expressing GATA-3
(Fig. 7C), we next addressed the question of whether or not I1
alone displayed classical (orientation- and position-indepen-
dent) tissue-specific enhancer activity. I1 was cloned 5′ to
308pCAT in both the sense and anti-sense orientations
(Materials and Methods), and was found to enhance promoter
activity very modestly in the sense orientation (Fig. 7G). In the
antisense orientation, I1 significantly suppressed promoter
activity in all three cell types (Fig. 7H). Thus, I1 does not act
as an enhancer of mGATA-3 transcription (Fig. 7G,H). 
In summary, these data indicate that at least two distinct cis-
regulatory regions lie within the 3 kbp surrounding the
mGATA-3 CAP site, which together act to confer significant
(>10-fold differential; Fig. 7D) tissue specificity controlling
mGATA-3 transcription after transient transfection into cell
lines. These regionally localized elements include a position-
dependent positive sequence within the mGATA-3 first intron
(compare Fig. 7A,C), as well a negative one between nt −308
and −1203 that suppresses mGATA-3 transcription in cells
Fig. 6. 5′ end analysis of GATA-3
mRNA. (A) GATA-3 mRNA isolated
from murine BW5147.3 T cells (lanes
1-3, 20 µg of cytoplasmic RNA) or
murine erythroleukemia cells (lanes
4-6, 40 µg of cytoplasmic RNA) was
hybridized to a radiolabelled primer
extension product of genomic
subclone R1.3 (Fig. 5A) and digested
with S1 nuclease as described
(Materials and Methods) for 20
minutes (lanes 1, 4), 40 minutes
(lanes 2, 5) or 60 minutes (lanes 3, 6).
At the same time, primer extension
reactions (Leonard and Patient, 1991)
were carried out using
oligonucleotide mG3PE1 (Materials
and Methods) to prime synthesis from either 10 (lane 11) or 20 (lane 12) µg of BW 5147.3 mRNA or 20 (lane 13) or 40 (lane 14) µg of MEL
cell mRNA. A sequencing reaction from genomic subclone R1.3 using mPE1 as primer was electrophoresed in parallel (lanes 7-10 are G, A, T
and C reactions, respectively). (B) Identical mRNAs to those used for the primer extension reactions shown in lanes 11-14 were carried out
using oligonucleotide mG3PE2 (lanes B1-4, respectively). Size markers (in nt) are shown on the left of both panels.
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where the gene is not normally transcribed (compare Fig.
7C,D). In their normal configuration and orientation within the
locus, these elements impart significant (>10-fold) cell-type-
specificity to mGATA-3 transcription after transient transfec-
tion.
Transcriptional regulation of mGATA-3: transgenic
mice
We next sought to determine whether the regulatory elements
identified by transient transfection analysis would also obey the
more stringent transcriptional criterion of directing appropri-
ate mGATA-3 regulation in vivo. Fertilized embryos were
injected with presumptive regulatory elements of the mGATA-
3 locus driving expression of the bacterial gene (lacZ)
encoding β-galactosidase (β-gal). A construct containing con-
tiguous sequences from −2052 through +1004 of mGATA-3
(the entire sequence shown in Fig. 5C) was fused to the
initiation codon of the lacZ gene, microinjected into fertilized
eggs and then transferred into pseudopregnant foster mothers.
Staged embryos were then stained for β-gal activity. Eight of
forty-five microinjected embryos were determined to be trans-
genic by Southern blot analysis, with transgene copy numbers
ranging from 4 to greater than 20 (data not shown). Four of the
eight transgenic embryos displayed β-gal expression; we
assume that the embryos that failed to express the reporter gene
reflect suppression due to integration site effects (Dillon and
Grosveld, 1993; Hogan et al., 1986). One of these embryos was
lost during manipulation, while the three remaining embryos
all exhibited β-gal staining.
Whole-mount staining of an e10 embryo displayed lacZ
expression in trigeminal and facio-acoustic ganglia, the sym-
pathetic trunk, the otic vesicle and somites (Fig. 8A,B). An
e11.5 embryo showed lower intensity staining in some cranial
nerves, somites and the ribs (Fig. 8C,D). An e12.5 embryo
showed strong β-gal activity in many ganglia of the PNS,
including the trigeminal and facio-acoustic ganglia, the sym-
pathetic trunk and dorsal root ganglia (Fig. 8E-G). In this
embryo, discrete staining is also detected in what appear to be
individual cells at the rostral end of the telencephalon, in the
eye, the vomeronasal organ and again in the ribs and ear.
Transverse sections of this embryo revealed low-level β-gal
activity in the ventral half of the spinal cord and in the neural
layer of the retina (data not shown). 
Clearly many regions of the e12.5 transgenic embryo display
a transgene staining pattern coincident with the mRNA
expression profile derived from in situ hybridization (Figs 1-3
and data not shown). One location displaying a clear difference
is the midbrain: in cross-sections of the e12.5 transgenic
embryo, no β-gal staining is observed in the mesencephalon or
pons region, while GATA-3 mRNA is clearly present in these
regions at this same stage (Fig. 2). Thus a transgene contain-
ing the mGATA-3 sequences shown in Fig. 5C, when linked to
a lacZ reporter gene, faithfully recapitulates almost the entire
normal expression pattern of mGATA-3 in transgenic mice,
with the exception that the very prominent CNS accumulation
of mGATA-3 is not reproduced. These data therefore confirm
and extend the transient transfection studies and indicate that
transcriptional control elements required for the tissue- and
developmental stage-specific expression of mGATA-3 lie
within approximately a 3 kbp segment of the gene (Fig. 5C),
but also that the element(s) conferring appropriate CNS regu-
lation likely lie outside these boundaries.
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Fig. 7. Expression of mGATA-
3-directed reporter genes in
transiently transfected murine
cell lines. The CAT reporter
gene, transcriptionally directed
by various segments of the
mGATA-3 locus (Fig. 5C), were
transfected into cell lines that
either express (BW 5147, black
bars; and C1300 cells, open bars)
or do not express (BALB/c 3T3
cells; shaded bars) mGATA-3
(Fig. 4). Cotransfected
pRSV.luciferase was used as the
internal control for transfection
efficiency (Materials and
Methods). Construction details
for the diagrammatic
representations shown in the
second column (Structure) are
given in Materials and Methods:
the thin line represents mGATA-
3 5′ flanking sequence, filled
boxes represent mGATA-3
exons, the first intron (I1) is
represented by the inflected line, and the open box represents the position of the CAT reporter gene. Each transfection was repeated, in
duplicate, on (at least) three separate occasions; the s.e.m. for the transfections was generally less than 25%. The values shown represent the
average CAT activity, normalized to that of a minimal promoter element [A) 308pCAT], which was arbitrarily assigned an activity of one in all
three cell types.
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DISCUSSION
In the present study, we describe the sites of most abundant
mGATA-3 expression from the onset of its first detectable
embryonic accumulation to e14.5 of development, as well as
the expression during T cell ontogeny and the cloning and
physical characterization of the mGATA-3 locus. In addition,
we present a preliminary regulatory analysis, which describes
Fig. 8. Expression of mGATA-
3-directed β-galactosidase
synthesis in transgenic murine
embryos. The entire sequence
shown in Fig. 5C was fused to
the bacterial lacZ gene and
injected into fertile mouse eggs.
At various times after
implantation, the embryos were
taken and stained for β-gal
activity. (A,B) Lateral and
dorsal views, respectively, of an
e10 transgenic embryo showing
β-galactosidase activity in
trigeminal ganglia (TG), facio-
acoustic ganglia (FA), the
sympathetic trunk (st), otic
vesicle (ov) and somites.
(C,D) Lateral and dorsal views,
respectively, of an e11.5 embryo
showing weak transgene
expression in some cranial
ganglia (cg), somites (so) and
the ribs (R). (E-G) Lateral,
dorsal and ventral views,
respectively, of an e12.5 embryo
showing transgene activity in
trigeminal and facio-acoustic
ganglia, the sympathetic trunk,
in dorsal root ganglia (drg) and
the eye (specifically, in the
neural retina; rt, see text), in the
vomeronasal organ (vno) and at
the rostral end of both lobes of
the telencephalon (t). The
position of the mesencephalon
(ms) is indicated.
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the overall sequence requirements for transcriptional control of
the mGATA-3 gene using both transient transfection into
GATA-3-expressing murine cell lines and analysis in trans-
genic mouse embryos. The obligatory first step in assigning
potential regulatory function(s) to a transcription factor is to
first clearly define its expression pattern. A dearth of informa-
tion presently exists regarding both the expression pattern and
regulation of GATA-3. The present studies should significantly
illuminate possibilities for when and where GATA-3 might
exert transcriptional regulatory effects.
Despite common features in overall GATA gene structure,
there may be significant differences in transcriptional initiation
and regulation between the GATA-1 and GATA-3 genes
(Hannon et al., 1991; Tsai et al., 1991). For example in T cells,
transcription of the mGATA-3 gene initiates at a single, distinct
site located 189 nucleotides 5′ to the first intron (Fig. 6), in
contrast to both mGATA-1 and cGATA-1, for which extensive
mRNA 5′ end heterogeneity was found in erythroid cells with
multiple, broadly scattered transcription initiation sites
(Hannon et al., 1991; Tsai et al., 1991). 
Transcriptional regulation of the mGATA-1 gene appears to
be dependent on a simple organization of two promoter
elements: one contains duplicated GATA sites, while a second
contains a duplication of a CACCC factor recognition motif.
Both motifs significantly contribute to expression of the
mGATA-1 gene in transient transfection assays since mutation
of either element results in a four-fold reduction in promoter
activity (Tsai et al., 1991), activation values similar to those
established in the transfection experiments reported here (Fig.
7). Regulation of the cGATA-1 gene promoter is somewhat
more complex, but again appears to involve GATA sites as a
critical autoregulatory element (Schwartzbauer et al., 1992).
Although GATA-binding sites were found within the mGATA-
3 first intron, site-specific mutation of these sites resulted in no
change in mGATA-3 transcriptional activity (K. G., unpub-
lished observations). 
The initial observation that GATA-3 is expressed in the
embryonic brain (Ko et al., 1991; Yamamoto et al., 1990) and
the further finding that it is also expressed in specific cell
layers of the chick optic lobes during embryonic development
(Kornhauser et al., 1994) prompted a more detailed analysis
of the embryonic expression pattern of mGATA-3 in the
murine CNS and PNS. We show here that GATA-3 expression
in the nervous system is quite low early in embryogenesis
(prior to e10), but later becomes localized to specific regions
of the nervous system (cranial/sympathetic ganglia, dien-
cephalon, mesencephalon, spinal cord). Several anatomically
distinct loci that express mGATA-3 at e12.5 (e.g. the telen-
cephalon, retina and spinal cord) fail to continue to express
the factor by e14.5. mGATA-3 expression in the spinal cord
at e10 is diffuse (Fig. 1H), becomes restricted to the ventral
half by e12.5 (Fig. 2G), and then declines by e14.5 (data not
shown) coincident with the time in development when spinal
cord neurons no longer undergo mitosis (Nornes and Carry,
1978). Thus, GATA-3 mRNA expression appears to undergo
both localized induction and suppression at a number of sites
during gestation.
By 12.5 days of gestation, mGATA-3 expression in the CNS
condenses within specific cell layers of the mesencephalon,
diencephalon and pons. mGATA-3-positive cells reside in the
outer layers of the mesencephalon, distal to the ventricle. In
this region of the brain, neuroblasts occupy the cell layers
directly bordering the ventricle and, as they cease mitosis,
these neurons migrate radially from the ventricular zone
(Angevine and Sidman, 1961). This suggests that GATA-3
expression corresponds to a specific stage of maturation during
the differentiation of CNS neurons, a view supported by
analogous studies of GATA factor expression in the develop-
ing optic lobes of the chicken (Kornhauser et al., 1994). 
Having determined the embryonic expression pattern of
mGATA-3 (Figs 1-3), it became of interest to define the
specific cis-regulatory elements required for the generation of
this highly restricted expression pattern. We therefore charac-
terized the genomic locus and then, by transient transfection
into cell lines, identified candidate transcriptional control
elements both in the first intron and in the distal part of the
promoter. However, given the rather modest differences in
activation of these reporter genes in the GATA-expressing and
-deficient cell lines (Fig. 7), and given the significant speci-
ficity of reporter gene control elicited by these same regulatory
sequences in vivo (Fig. 8), we are uncertain as to the continued
efficacy of using transient transfections to refine the possible
in vivo transcriptional regulatory mechanisms that are
employed in controlling this gene.
To determine whether the regulatory elements identified by
transfection into cell lines represent functional regulatory
elements in vivo, the bacterial lacZ gene was used to create an
mGATA-3 regulatory sequence-directed transgene. When
injected into fertilized mouse eggs, this transgene recapitulates
the normal mGATA-3 expression profile almost entirely,
including expression in cranial and sympathetic ganglia, dorsal
root ganglia, spinal cord, retina, somites and vomeronasal
organ. The most notable exception to the in vivo mRNA
expression pattern is the absence of β-gal staining in the
midbrain, and we therefore conclude that this transgene does
not contain the full complement of regulatory sequences
required for complete transcriptional control of mGATA-3. We
are currently examining other segments of the locus to recon-
struct the complete regulatory pattern of mGATA-3 transcrip-
tion, and are also extending these observations using anti-
mGATA-3 antisera to determine whether GATA-3 expression
in the CNS might be post-transcriptionally controlled (M. E.
R., unpublished observations).
Since mGATA-3 displays a complex pattern of expression
during development and since the trangenic embryos represent
transiently analyzed animals examined at different days of
gestation, these initial transgenic studies must be interpreted
with considerable caution. However, each of the transgenic
embryos displayed staining patterns that are similar to those
resolved by mRNA in situ hybridization analysis at compara-
ble stages, and each also showed an expression pattern that was
developmentally consistent from animal to animal. These
initial results therefore indicate that the segment of the
mGATA-3 locus from nt −2052 to +1004 is necessary, but not
sufficient, to recapitulate accurately the endogenous mGATA-
3 transcription pattern. As with all transgenic analysis, position
effects and mosaicism in founder embryos must be accounted
for, and thus further analysis of transcriptional regulation of
mGATA-3 using established lines to refine the activity of iden-
tified elements (e.g. in the PNS and kidney), as well as to
identify currently undefined elements (e.g. in the CNS),
appears to be clearly warranted. 
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